David Kandzari

Atlanta

Featured in: Favicon

oxfordjournals.org Favicon

thelancet.com Favicon

healio.com Favicon

onlinejacc.org Favicon

pcronline.com Favicon

radcliffecardiology.com Favicon

onlinelibrary.wiley.com Favicon

eurheartj.oxfordjournals.org + 1 more

Articles

Modest, mixed BP benefits seen with alcohol-mediated renal denervation: TARGET BP-1

Apr 8, 2024 | healio.com | Regina Schaffer |Katie Kalvaitis |Keith C. Ferdinand |David Kandzari

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Alcohol-mediated renal nerve denervation is a novel strategy for people with uncontrolled and treatment-resistant hypertension. There was a large placebo effect seen in the sham group.
Ultrathin bioresorbable polymer sirolimus‐eluting stents in US patients undergoing coronary revascularization: 1‐Year outcomes from the BIOFLOW VII trial - Kandzari - Catheterization and Cardiovascular Interventions - Wiley Online Library

Jul 26, 2023 | onlinelibrary.wiley.com | David Kandzari |Hector M. Garcia-Garcia |Robert C. Stoler |Baylor Scott

Abstract Background Ultrathin strut coronary drug-eluting stents (DES) have demonstrated improved safety and efficacy in large contemporary trials. The evaluation of an ultrathin strut DES in a post-market United States (US) patient population was undertaken.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →